Compare SITM & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SITM | BAX |
|---|---|---|
| Founded | 2003 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 10.2B |
| IPO Year | 2019 | 1994 |
| Metric | SITM | BAX |
|---|---|---|
| Price | $339.05 | $17.88 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 9 |
| Target Price | ★ $390.71 | $22.38 |
| AVG Volume (30 Days) | 356.8K | ★ 9.5M |
| Earning Date | 05-06-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 0.22% |
| EPS Growth | ★ 57.53 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $326,660,000.00 | ★ $11,244,000,000.00 |
| Revenue This Year | $49.65 | $1.83 |
| Revenue Next Year | $27.77 | $2.28 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 61.16 | 5.72 |
| 52 Week Low | $105.42 | $17.40 |
| 52 Week High | $446.96 | $37.74 |
| Indicator | SITM | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 37.69 | 33.50 |
| Support Level | $262.61 | $17.69 |
| Resistance Level | $387.13 | $19.31 |
| Average True Range (ATR) | 27.27 | 0.79 |
| MACD | -9.08 | -0.36 |
| Stochastic Oscillator | 0.27 | 8.03 |
SiTime Corp is a provider of silicon timing systems solutions. The company designs develops and sell silicon timing systems solutions for different industries including automotive, infrastructure, aerospace-defense, consumer, internet of things, consumer and industrials. Its product offerings include Stratum 3E DCOCXOs, Programmable OCXOs, MHz Oscillators, 32.768 kHz Oscillators, Embedded Resonators, Precision MHz Super-TCXOs, and Ruggedized Oscillators. It sells its products around Taiwan, Hong Kong, the United States, and other regions and generates the majority of its revenue from Taiwan.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.